Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Capital Medical University is the lead sponsor of 67 current clinical trials in our China register. 41 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Tocilizumab, Ad-TD-nsIL12 and Oseltamivir. The most-studied condition is Acute Ischemic Stroke.

ClinicalTrials.gov trials by status

Recruiting4161%
Not yet open1725%
Active, closed710%
By invitation23%

Trials by phase

Not applicable3248%
Observational1421%
Phase 31116%
Phase 157%
Phase 223%
Phase 1/211%
Phase 411%
Phase EARLY_PHASE111%

Clinical trials sponsored by Capital Medical University

67 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Telemedicine-supported Management for Acute Ischemic Stroke NCT07302971 · Acute Ischemic Stroke	Not applicable	Recruiting	2026-02	China
Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis NCT04850053 · ClinicalTrials.gov ↗ · Alzheimer's Disease	Observational	Recruiting	2020-08	China
Study on Biomarkers for Early Diagnosis of Alzheimer's Disease NCT04575337 · ClinicalTrials.gov ↗ · Alzheimer Disease	Observational	Recruiting	2020-05	China
Effects of Tracheostomy Decannulation on Respiratory Function NCT07191509 · ClinicalTrials.gov ↗ · Tracheostomy Decannulation	Observational	Recruiting	2025-10	China
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer NCT06584318 · ClinicalTrials.gov ↗ · Colorectal Cancer	Not applicable	Recruiting	2024-03	China
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke NCT07509645 · ClinicalTrials.gov ↗ · Ischemic Stroke Drug: Tocilizumab	Phase 3	Recruiting	2026-04	China
Evaluating the Short-term Efficacy of Two Oscillation Techniques in Hypersecretive Mechanically Ventilated Patients NCT06675942 · ClinicalTrials.gov ↗ · Hypersecretive Mechanically Ventilated Patients	Not applicable	Recruiting	2024-11	China
Urokinase for Thrombolysis in Acute Ischemic Stroke NCT07047326 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Not applicable	Recruiting	2025-10	China
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) NCT06548971 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke, Cerebral Infarction Drug: Aspirin	Phase 3	Recruiting	2024-11	China
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease NCT05020106 · ClinicalTrials.gov ↗ · Alzheimer's Disease	Observational	Recruiting	2018-09	China
Prognostic Biomarkers for Selective Intra-Arterial Cooling Infusion Combined with Endovascular Thrombectomy in Acute Ischemic Stroke Based on Proteomics and Metabolomics. NCT06665386 · ClinicalTrials.gov ↗ · Stroke, Hypothermia Treatment	Observational	Recruiting	2024-10	China
China Cognition and Aging Study NCT03653156 · ClinicalTrials.gov ↗ · Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD)	Observational	Recruiting	2000-01	China
Cerebral Venous Thrombosis Cohort Study in China Mainland NCT03919305 · ClinicalTrials.gov ↗ · Cerebral Venous Sinus Thrombosis, Deep Cerebral Vein Thrombosis, Cortical Vein Thrombosis	Observational	Recruiting	2019-01	China
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) NCT07800572 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Phase 2	Recruiting	2026-09	China
App and Body Fat Scale in the Management of Overweight Patients NCT05866107 · ClinicalTrials.gov ↗ · Schizophrenia, Bipolar Disorder, Metabolic Syndrome	Not applicable	Recruiting	2023-10	China
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2 NCT07139314 · ClinicalTrials.gov ↗ · Ischemic Stroke, Atrial Fibrillation	Not applicable	Recruiting	2025-09	China
Artificial Intelligence Support for Stroke NCT07785492 · ClinicalTrials.gov ↗ · Ischemic Stroke, Acute	Not applicable	Recruiting	2026-08	China
Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis NCT07801638 · ClinicalTrials.gov ↗ · Cerebral Venous Thrombosis Drug: Tocilizumab	Not applicable	Recruiting	2025-03	China
SV With TTPEE Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients NCT07107243 · ClinicalTrials.gov ↗ · Tracheostomy	Not applicable	Recruiting	2025-10	China
RAPART in Locally Advanced Non-small Cell Lung Cancer Patients NCT07164885 · ClinicalTrials.gov ↗ · Locally Advanced Non-small Cell Lung Cancer	Not applicable	Recruiting	2025-02	China
Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy NCT03546309 · ClinicalTrials.gov ↗ · Moyamoya Disease, Pediatric	Not applicable	Recruiting	2024-09	China
A Pilot Trial of Pressure Muscle Index-Targeted PSV Trial NCT06769360 · ClinicalTrials.gov ↗ · Critical Care, Acute Hypoxic Respiratory Failure, Ventilator Lung	Not applicable	Recruiting	2025-01	China
Study on Hibernation-like Therapy Based on Mechanical Thrombectomy NCT06663631 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke Drug: Rt-PA	Phase 1	Recruiting	2024-11	China
EIT-Guided Respiratory Physiotherapy for Prolonged Mechanical Ventilation (PMV) NCT07372794 · ClinicalTrials.gov ↗ · Prolonged Mechanical Ventilation, Respiratory Failure, Critical Illness	Not applicable	Recruiting	2026-02	China
Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting NCT07236814 · ClinicalTrials.gov ↗ · Influenza Drug: Oseltamivir	Phase 3	Recruiting	2025-11	China
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma NCT05717699 · ClinicalTrials.gov ↗ · Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Drug: Ad-TD-nsIL12	Phase 1	Recruiting	2023-01	China
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT） NCT06559241 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke, Anterior Circulation Brain Infarction	Phase 3	Recruiting	2024-09	China
The Chinese Familial Alzheimer's Network NCT03657732 · ClinicalTrials.gov ↗ · Alzheimer Disease, Familial Alzheimer Disease (FAD)	Observational	Recruiting	2005-01	China
Integrated Diagnosis and Treatment of CKD on Outcomes NCT05242055 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases, Hypertension, Hyperglycemia	Observational	Recruiting	2022-02	China
Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea NCT07277608 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea	Observational	Recruiting	2023-08	China
The Effect of Oscillation and Lung Expansion (OLE) Therapy in Prolonged Mechanical Ventilated Patients With Atelectasis Evaluated in Multiple Methods NCT07451405 · ClinicalTrials.gov ↗ · Atelectasis	Not applicable	Recruiting	2026-03	China
Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial NCT06526598 · ClinicalTrials.gov ↗ · Critical Care, Acute Hypoxic Respiratory Failure, Ventilator-Induced Lung Injury	Not applicable	Recruiting	2026-01	China
Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-2) NCT05789823 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Phase 2	Recruiting	2023-11	China
Basilar Artery Occlusion Chinese Endovascular Trial in the Extended Time Window NCT06560203 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke, Basilar Artery Occlusion	Not applicable	Recruiting	2024-09	China
Normobaric Oxygen in AIS Transferred for EVT NCT06666764 · ClinicalTrials.gov ↗ · Ischemic Stroke	Phase 3	Recruiting	2024-12	China
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma NCT05717712 · ClinicalTrials.gov ↗ · Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Drug: Ad-TD-nsIL12	Phase 1	Recruiting	2023-01	China
Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation (MIRACLE-L) NCT06688201 · ClinicalTrials.gov ↗ · Intracerebral Hemorrhage	Not applicable	Recruiting	2025-01	China
Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis NCT07242768 · ClinicalTrials.gov ↗ · Ischemic Stroke, Transient Ischemic Attack	Observational	Recruiting	2026-01	China
IN10018 in Combination With Dalpiciclib for Progressive Meningiomas NCT07652762 · ClinicalTrials.gov ↗ · Meningioma, CDK4/6 Inhibitor Drug: Dalpiciclib	Phase 1	Recruiting	2026-08	China
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2 NCT07263308 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke Drug: Albumin	Phase 3	Recruiting	2025-12	China
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation NCT07139301 · ClinicalTrials.gov ↗ · Ischemic Stroke, Atrial Fibrillation	Not applicable	Recruiting	2025-09	China
Context-Guided Personalized iTBS for Depression NCT07743398 · ClinicalTrials.gov ↗ · Major Depressive Disorder (MDD)	Not applicable	Not yet open	2026-09	China
PCOT for Outpatients With Acute Respiratory Tract Infection at Risk of Severe Disease in Primary Healthcare NCT07159230 · ClinicalTrials.gov ↗ · Acute Respiratory Tract Infection	Not applicable	Not yet open	2025-09	China
Titration of PS Guided by FI : A Pilot Study NCT07769307 · ClinicalTrials.gov ↗ · Mechanical Ventilation	Not applicable	Not yet open	2026-09	China
Effects of Music Therapy on Anxiety Symptoms in Patients With Prolonged Mechanical Ventilation: A Randomized Controlled Trial NCT07560384 · ClinicalTrials.gov ↗ · Anxiety, Prolonged Mechanical Ventilation	Not applicable	Not yet open	2026-05	China
Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke NCT06801457 · ClinicalTrials.gov ↗ · Stroke Acute	Phase 3	Not yet open	2025-02	China
Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting NCT06762587 · ClinicalTrials.gov ↗ · Influenza, Influenza Prophylaxis, Nosocomial Infection Drugs: Baloxavir Marboxil, Oseltamivir	Not applicable	Not yet open	2025-01	China
Effect of Target Temperature Management on Intestinal Flora and Its Metabolites in Patients With Cardiac Arrest NCT06974682 · ClinicalTrials.gov ↗ · Cardiac Arrest (CA)	Observational	Not yet open	2025-09	China
Effects of Functional Oils on Obesity With Mild Cognitive Impairment NCT07690384 · ClinicalTrials.gov ↗ · Obesity, Mild Cognitive Impairment	Not applicable	Not yet open	2026-07	China
Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke NCT06374823 · ClinicalTrials.gov ↗ · Critical Care, Hyperchloremia, Hemorrhagic Stroke	Phase 4	Not yet open	2024-05	China
Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing NCT06489990 · ClinicalTrials.gov ↗ · Depression, Obesity, High Risk of Depression	Not applicable	Not yet open	2024-08	China
Intra-arterial Hypothermic Magnesium Sulfate Infusion in Combination with Endovascular Thrombectomy in Acute Ischemic Stroke NCT06760195 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Phase EARLY_PHASE1	Not yet open	2025-01	China
Exercise Intervention for Breast Cancer Patients With Sarcopenia NCT07732101 · ClinicalTrials.gov ↗ · Sarcopenia, Breast Cancer	Not applicable	Not yet open	2026-09	China
Basilar Artery Occlusion Chinese Endovascular Trial in Patients With Large Core Infarct NCT07046299 · ClinicalTrials.gov ↗ · Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct	Not applicable	Not yet open	2025-07	China
PET-CT to Assess Brain Damage in Cardiac Arrest Patients NCT06660238 · ClinicalTrials.gov ↗ · Cardiac Arrest, Brain Injuries	Observational	Not yet open	2025-05	China
MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD NCT06779344 · ClinicalTrials.gov ↗ · Acute Exacerbation Chronic Obstructive Pulmonary Disease	Not applicable	Not yet open	2025-01	China
Efficacy and Safety of Inhaled Peramivir Solution for the Treatment of Adults With Uncomplicated Influenza NCT07791251 · ClinicalTrials.gov ↗ · Influenza Infection	Phase 3	Not yet open	2026-10	China
Effect of tNGS on CAP Patients With Initial Treatment Failure NCT07472114 · ClinicalTrials.gov ↗ · Community Acquired Pneumonia (CAP)	Not applicable	Not yet open	2026-04	China
Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke NCT07163299 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Phase 1/2	By invitation	2025-09	China
Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage--Small Hemorrhage Evacuation (MIRACLE-S) NCT06688162 · ClinicalTrials.gov ↗ · Intracerebral Hemorrhage	Not applicable	By invitation	2025-01	China
Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis NCT06615726 · ClinicalTrials.gov ↗ · Ischemic Stroke, Transient Ischemic Attack	Phase 3	Active, closed	2024-10	China
Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke NCT07271082 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Not applicable	Active, closed	2025-12	China
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2 NCT07263776 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke Drug: Tocilizumab	Phase 3	Active, closed	2025-12	China
Intracranial Arterial Stenosis in Young Patients NCT05844176 · ClinicalTrials.gov ↗ · Intracranial Arterial Stenosis	Observational	Active, closed	2022-06	China
Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment NCT07486141 · ClinicalTrials.gov ↗ · Mild Cognitive Impairment	Not applicable	Active, closed	2024-11	China
Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia NCT03804229 · ClinicalTrials.gov ↗ · Vascular Dementia	Phase 3	Active, closed	2019-10	China
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) NCT07513233 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Phase 1	Active, closed	2026-04	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Capital Medical University trials

8 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Tocilizumab3 Ad-TD-nsIL122 Oseltamivir2 Albumin1 Aspirin1 Baloxavir Marboxil1 Dalpiciclib1 Rt-PA1

Conditions in Capital Medical University trials

76 conditions

Acute Ischemic Stroke14 Ischemic Stroke7Critical Care3Alzheimer's Disease2 Alzheimer Disease2Transient Ischemic Attack2Familial Alzheimer Disease (FAD)2Intracerebral Hemorrhage2Prolonged Mechanical Ventilation2Atrial Fibrillation2Acute Hypoxic Respiratory Failure2Influenza2Oncolytic Virus2Diffuse Intrinsic Pontine Glioma2Adverse Drug Event2Obesity2 Mild Cognitive Impairment2Basilar Artery Occlusion2Tracheostomy Decannulation1Colorectal Cancer1 Major Depressive Disorder (MDD)1Hypersecretive Mechanically Ventilated Patients1Cerebral Infarction1 Stroke1

By trial register

Register	Trials	Recruiting
Clinical trials in China	67	41

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Acute Ischemic Stroke

Sponsor	Trials
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	7
Xuanwu Hospital, Beijing	6
Nanfang Hospital, Southern Medical University	4
Beijing Anzhen Hospital	4
Yi Yang	4
The First Affiliated Hospital of University of Science and Technology of China	4
The First Affiliated Hospital of Zhengzhou University	3
Xiang Luo	3
Shanghai Pharmaceuticals Holding	2
First Affiliated Hospital Xi'an Jiaotong University	2

Sponsors with the most current trials registered for this condition.

Questions about Capital Medical University trials

How many clinical trials does Capital Medical University sponsor?

Capital Medical University is the lead sponsor of 67 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Capital Medical University trials recruiting?

Yes. 41 of its 67 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Capital Medical University testing?

Its current trials name 8 drugs and biologicals as interventions. The most frequent are Tocilizumab (3), Ad-TD-nsIL12 (2), Oseltamivir (2), Albumin (1) and Aspirin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Capital Medical University clinical trials